According to the latest research, the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University and pharmaceutical companies have collaborated to create artificial intelligence (AI) tools that will help patients with non-small cell lung cancer (NSCLC) based on an analysis of typical tissue biopsy images.